Abstract:Purpose The aim of this study was to assess the potential of machine learning with multiparametric magnetic resonance imaging (mpMRI) for the early prediction of pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) and of survival outcomes in breast cancer patients. Materials and Methods This institutional review board–approved prospective study included 38 women (median age, 46.5 years; range, 25–70 years) with breast cancer who were scheduled for NAC and underwent mpMRI of the breast at 3 T with dynamic contrast-enhanced (DCE), diffusion-weighted imaging (DWI), and T2-weighted imaging before and after 2 cycles of NAC. For each lesion, 23 features were extracted: qualitative T2-weighted and DCE-MRI features according to BI-RADS (Breast Imaging Reporting and Data System), quantitative pharmacokinetic DCE features (mean plasma flow, volume distribution, mean transit time), and DWI apparent diffusion coefficient (ADC) values. To apply machine learning to mpMRI, 8 classifiers including linear support vector machine, linear discriminant analysis, logistic regression, random forests, stochastic gradient descent, decision tree, adaptive boosting, and extreme gradient boosting (XGBoost) were used to rank the features. Histopathologic residual cancer burden (RCB) class (with RCB 0 being a pCR), recurrence-free survival (RFS), and disease-specific survival (DSS) were used as the standards of reference. Classification accuracy with area under the receiving operating characteristic curve (AUC) was assessed using all the extracted qualitative and quantitative features for pCR as defined by RCB class, RFS, and DSS using recursive feature elimination. To overcome overfitting, 4-fold cross-validation was used. Results Machine learning with mpMRI achieved stable performance as shown by mean classification accuracies for the prediction of RCB class (AUC, 0.86) and DSS (AUC, 0.92) based on XGBoost and the prediction of RFS (AUC, 0.83) with logistic regression. The XGBoost classifier achieved the most stable performance with high accuracies compared with other classifiers. The most relevant features for the prediction of RCB class were as follows: changes in lesion size, complete pattern of shrinkage, and mean transit time on DCE-MRI; minimum ADC on DWI; and peritumoral edema on T2-weighted imaging. The most relevant features for prediction of RFS were as follows: volume distribution, mean plasma flow, and mean transit time; DCE-MRI lesion size; minimum, maximum, and mean ADC with DWI. The most relevant features for prediction of DSS were as follows: lesion size, volume distribution, and mean plasma flow on DCE-MRI, and maximum ADC with DWI. Conclusions Machine learning with mpMRI of the breast enables early prediction of pCR to NAC as well as survival outcomes in breast cancer patients with high accuracy and thus may provide valuable predictive information to guide treatment decisions.

Breast Cancer Prognosis Using a Machine Learning Approach

Evaluation of Machine Learning Algorithms for the Prognosis of Breast Cancer from the Surveillance, Epidemiology, and End Results Database

Machine Learning techniques in breast cancer prognosis prediction: A primary evaluation

Breast Cancer Prediction Based on Machine Learning

Breast Cancer Surgery 10-Year Survival Prediction by Machine Learning: A Large Prospective Cohort Study

Supervised Machine Learning for Breast Cancer Risk Factors Analysis and Survival Prediction

Predicting diagnosis and survival of bone metastasis in breast cancer using machine learning

Predicting factors for survival of breast cancer patients using machine learning techniques

Prediction of Breast Cancer using Machine Learning Approaches

Machine learning techniques in breast cancer preventive diagnosis: a review

Breast Cancer Prediction Based on Multiple Machine Learning Algorithms

Application of machine learning for lung cancer survival prognostication—A systematic review and meta-analysis

Breast Cancer Survival Analysis Agents for Clinical Decision Support

Breast cancer outcome prediction with tumour tissue images and machine learning

Machine learning applications in breast cancer survival and therapeutic outcome prediction based on multi-omic analysis

A machine learning approach applied to gynecological ultrasound to predict progression-free survival in ovarian cancer patients

From Data Mining of Public Sources to Clinical Decision Support in Personalized Medicine

Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients

Applications of Machine Learning in Cancer Prediction and Prognosis

The Application and Comparison of Machine Learning Models for the Prediction of Breast Cancer Prognosis: Retrospective Cohort Study

Machine learning-informed liquid-liquid phase separation for personalized breast cancer treatment assessment